Table 2: Showing treatment pattern and compliance of the patient
cohort.
|
Parameter |
Number (%) (N = 100) |
|
Neoadjuvant Chemotherapy |
15 (15%) |
|
Paclitaxel + Carboplatin |
11 (11%) |
|
Others |
04 (4%) |
|
Concurrent Chemotherapy |
54 (54%) |
|
Cisplatin |
33 (33%) |
|
Paclitaxel + Carboplatin |
21 (21%) |
|
Radiation Technique |
|
|
3DCRT |
76 (76%) |
|
IMRT |
24 (24%) |
|
Radiation Dose |
|
|
Range |
45 – 63Gy |
|
Mean ± S.D |
57.84 ±5.72 |
|
Median (IQR) |
59.4Gy (10.8) |
|
50.4Gy |
25 (25%) |
|
> 50.4Gy |
75 (75%) |
|
Treatment Compliance |
|
|
Completed |
90 (90%) |
|
Defaulted |
10 (10%) |
3DCRT: 3-Dimensional Conformal Radiotherapy Technique;
IMRT: Intensity Modulated Radiotherapy Technique.